$ROIV
Roivant Sciences Ltd. Stock $roiv

$roiv Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000114036122041175 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2022 Q1
Revenue	$17.05M	$12.53M	$9.223M
YoY Change	-29.95%	-10.4%	-39.11%
Cost Of Revenue	$3.586M	$3.641M	$459.0K
YoY Change	159.1%	-42.94%	-3.97%
Gross Profit	$13.47M	$8.892M	$8.764M
YoY Change	-41.34%	16.91%	-40.25%
Gross Profit Margin	78.97%	70.95%	95.02%
Selling, General & Admin	$168.3M	$157.7M	$139.0M
YoY Change	45.64%	-63.99%	71.26%
% of Gross Profit	1249.52%	1773.09%	1585.73%
Research & Development	$125.5M	$132.0M	$136.6M
YoY Change	-18.19%	-48.09%	-71.2%
% of Gross Profit	932.22%	1484.42%	1558.58%
Depreciation & Amortization	$5.151M	$7.753M
YoY Change
% of Gross Profit	38.25%	87.19%
Operating Expenses	$395.1M	$293.3M	$275.6M
YoY Change	46.9%	-57.62%	-50.39%
Operating Profit	-$378.1M	-$280.8M	-$266.8M
YoY Change	53.68%	-58.98%	-50.67%
Interest Expense	$27.75M	-$57.34M	-$74.21M
YoY Change	-170.31%	-112.08%	503.81%
% of Operating Profit
Other Income/Expense, Net	$19.90M	-$8.615M	$44.50M
YoY Change	-196.81%	-43.87%	-542.43%
Pretax Income	-$382.1M	-$313.8M	-$291.5M
YoY Change	24.84%	39.3%	-48.24%
Income Tax	$2.819M	$2.165M	-$163.0K
% Of Pretax Income
Net Earnings	-$352.0M	-$291.6M	-$270.1M
YoY Change	15.01%	29.23%	-47.0%
Net Earnings / Revenue	-2064.36%	-2326.58%	-2928.14%
Basic Earnings Per Share	-$0.49	-$0.42
Diluted Earnings Per Share	-$0.49	-$0.42	-$390.1K
COMMON SHARES
Basic Shares Outstanding	725.4M	703.6M
Diluted Shares Outstanding	713.3M	699.9M

Balance Sheet

Concept	2022 Q4	2022 Q3	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.527B	$1.599B	$2.060B
YoY Change	-31.02%	-35.97%	141023.29%
Cash & Equivalents	$1.527B	$1.599B	$2.060B
Short-Term Investments
Other Short-Term Assets	$118.8M	$111.8M	$82.22M
YoY Change	92.53%	142.58%	34158.33%
Inventory			$0.00
Prepaid Expenses	$69.51M	$70.30M	$53.37M
Receivables	$27.97M	$25.04M
Other Receivables	$1.487M	$2.331M
Total Short-Term Assets	$1.646B	$1.715B	$2.147B
YoY Change	-28.03%	-32.9%	126166.06%
LONG-TERM ASSETS
Property, Plant & Equipment	$37.30M	$39.17M	$25.91M
YoY Change	-55.22%	-51.1%
Goodwill
YoY Change
Intangibles	$146.1M	$140.3M	$0.00
YoY Change
Long-Term Investments	$272.5M	$246.6M	$325.8M
YoY Change	-31.67%	-43.54%	-20.68%
Other Assets	$46.22M	$11.87M	$16.09M
YoY Change	55.05%	-60.77%
Total Long-Term Assets	$556.7M	$500.7M	$438.6M
YoY Change	8.77%	-8.49%	6.77%
TOTAL ASSETS
Total Short-Term Assets	$1.646B	$1.715B	$2.147B
Total Long-Term Assets	$556.7M	$500.7M	$438.6M
Total Assets	$2.203B	$2.216B	$2.585B
YoY Change	-21.31%	-28.6%	526.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$48.00M	$41.36M	$34.58M
YoY Change	97.06%	-46.4%	31339.09%
Accrued Expenses	$132.4M	$128.8M	$127.5M
YoY Change	6.81%	11.4%	591.22%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$37.72M	$35.75M	$0.00
YoY Change
Total Short-Term Liabilities	$244.3M	$230.7M	$184.4M
YoY Change	51.98%	-23.96%	892.29%
LONG-TERM LIABILITIES
Long-Term Debt	$375.1M	$376.1M	$210.0M
YoY Change	83.85%	88.15%
Other Long-Term Liabilities	$21.48M	$9.104M	$8.183M
YoY Change	-86.97%	-93.88%	-68.7%
Total Long-Term Liabilities	$21.48M	$9.104M	$8.183M
YoY Change	-94.18%	-97.39%	-68.7%
TOTAL LIABILITIES
Total Short-Term Liabilities	$244.3M	$230.7M	$184.4M
Total Long-Term Liabilities	$21.48M	$9.104M	$8.183M
Total Liabilities	$775.8M	$701.4M	$523.7M
YoY Change	-16.9%	-34.14%	1071.05%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.700B	-$3.387B	-$2.764B
YoY Change		53.32%	44.06%
Common Stock	$0.00	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$955.5M	$1.161B	$1.657B
YoY Change
Total Liabilities & Shareholders Equity	$2.203B	$2.216B	$2.585B
YoY Change	-21.31%	-28.6%	526.71%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2022 Q1
OPERATING ACTIVITIES
Net Income	-$352.0M	-$291.6M	-$270.1M
YoY Change	15.01%	29.23%	-47.0%
Depreciation, Depletion And Amortization	$5.151M	$7.753M
YoY Change
Cash From Operating Activities	-$222.6M	-$189.6M	-$147.5M
YoY Change	-17.1%	57.24%	-73.29%
INVESTING ACTIVITIES
Capital Expenditures	$508.0K	-$3.101M	-$6.263M
YoY Change	-108.36%	12.31%	7.87%
Acquisitions
YoY Change
Other Investing Activities	-$3.003M	-$143.8M	$561.0K
YoY Change		-144.9%	-102.17%
Cash From Investing Activities	-$3.511M	-$146.9M	-$5.702M
YoY Change	-42.19%	-146.27%	-82.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	154.5M	-7.341M	1.070M
YoY Change	-1934.42%	-102.42%	-99.77%
NET CHANGE
Cash From Operating Activities	-222.6M	-189.6M	-147.5M
Cash From Investing Activities	-3.511M	-146.9M	-5.702M
Cash From Financing Activities	154.5M	-7.341M	1.070M
Net Change In Cash	-71.61M	-343.8M	-152.1M
YoY Change	-74.7%	-168.66%	19.22%
FREE CASH FLOW
Cash From Operating Activities	-$222.6M	-$189.6M	-$147.5M
Capital Expenditures	$508.0K	-$3.101M	-$6.263M
Free Cash Flow	-$223.1M	-$186.5M	-$141.2M
YoY Change	-14.98%	58.3%	-74.15%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	725418787
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001635088
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40782
	dei	Entity Registrant Name EntityRegistrantName	ROIVANT SCIENCES LTD.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	D0
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1173944
	dei	Entity Address Address Line1 EntityAddressAddressLine1	7th Floor
	dei	Entity Address Address Line2 EntityAddressAddressLine2	50 Broadway
	dei	Entity Address City Or Town EntityAddressCityOrTown	London
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	SW1H 0DB
	dei	Entity Address Country EntityAddressCountry	GB
	dei	Country Region CountryRegion	44
	dei	City Area Code CityAreaCode	207
	dei	Local Phone Number LocalPhoneNumber	400 3347
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	3993000
CY2022Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	3903000
CY2022Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	9632000
CY2022Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	9731000
CY2022Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	8373000
CY2022Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	10147000
CY2022Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	11901000
CY2022Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	13740000
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1514149000
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-353784000
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1755391000
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2039514000
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2038943000
CY2022Q2	roiv	Issuance Of Subsidiary Common Shares To The Company Value IssuanceOfSubsidiaryCommonSharesToTheCompanyValue	0
CY2022Q2	roiv	Stock Issued During Period Value Stock Options Exercised And Equity Instruments Vested And Settled Net Of Tax StockIssuedDuringPeriodValueStockOptionsExercisedAndEquityInstrumentsVestedAndSettledNetOfTax	8329000
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0
CY2022Q2	roiv	Apic And Noncontrolling Interest Share Based Payment Arrangement Increase For Cost Recognition APICAndNoncontrollingInterestShareBasedPaymentArrangementIncreaseForCostRecognition	72794000
CY2022Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	5767000
CY2022Q3	roiv	Issuance Of Subsidiary Common Shares To The Company Value IssuanceOfSubsidiaryCommonSharesToTheCompanyValue	0
CY2022Q3	roiv	Equity Instruments Vested And Settled Value EquityInstrumentsVestedAndSettledValue	0
CY2022Q3	roiv	Stock Issued During Period Common Shares And Other Consideration For Acquisition Value StockIssuedDuringPeriodCommonSharesAndOtherConsiderationForAcquisitionValue	8948000
CY2022Q3	roiv	Capital Contributions To Subsidiaries CapitalContributionsToSubsidiaries	0
CY2022Q3	roiv	Apic And Noncontrolling Interest Share Based Payment Arrangement Increase For Cost Recognition APICAndNoncontrollingInterestShareBasedPaymentArrangementIncreaseForCostRecognition	61979000
CY2022Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	3752000
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-315921000
CY2021Q2	roiv	Issuance Of Subsidiary Warrants Value IssuanceOfSubsidiaryWarrantsValue	2075000
CY2021Q2	roiv	Capital Contributions To Subsidiaries CapitalContributionsToSubsidiaries	0
CY2021Q2	roiv	Apic And Noncontrolling Interest Share Based Payment Arrangement Increase For Cost Recognition APICAndNoncontrollingInterestShareBasedPaymentArrangementIncreaseForCostRecognition	19269000
CY2021Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-2439000
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-101078000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	18569000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1447000
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1957341000
CY2021Q3	roiv	Stock Issued During Period Value Common Shares Upon Closing Of Business Combination And Pipe Financing StockIssuedDuringPeriodValueCommonSharesUponClosingOfBusinessCombinationAndPipeFinancing	-129097000
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0
CY2021Q3	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	70000000
CY2021Q3	roiv	Issuance Of Subsidiary Common And Preferred Shares Value IssuanceOfSubsidiaryCommonAndPreferredSharesValue	0
CY2021Q3	roiv	Adjustments Of Payment Of Subscription Receivable Value AdjustmentsOfPaymentOfSubscriptionReceivableValue	-100000000
CY2021Q3	roiv	Capital Contributions To Subsidiaries CapitalContributionsToSubsidiaries	0
CY2021Q3	roiv	Apic And Noncontrolling Interest Share Based Payment Arrangement Increase For Cost Recognition APICAndNoncontrollingInterestShareBasedPaymentArrangementIncreaseForCostRecognition	397312000
CY2021Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2247000
CY2021Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	2545000
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-225640000
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2428408000
	us-gaap	Profit Loss ProfitLoss	-669705000
	us-gaap	Profit Loss ProfitLoss	-326718000
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	72107000
	us-gaap	Share Based Compensation ShareBasedCompensation	134773000
	us-gaap	Share Based Compensation ShareBasedCompensation	416581000
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-79225000
	us-gaap	Gain Loss On Investments GainLossOnInvestments	23654000
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	443754000
	roiv	Gain Loss On Fair Value Of Debt And Liability Instruments GainLossOnFairValueOfDebtAndLiabilityInstruments	-27672000
	roiv	Gain Loss On Fair Value Of Debt And Liability Instruments GainLossOnFairValueOfDebtAndLiabilityInstruments	-17730000
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	16762000
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	0
	roiv	Gain On Termination Of Equity Interest Options GainOnTerminationOfEquityInterestOptions	0
	roiv	Gain On Termination Of Equity Interest Options GainOnTerminationOfEquityInterestOptions	61472000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7753000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2856000
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	4194000
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	3660000
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-8716000
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-758000
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	6774000
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	56510000
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-4753000
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-2537000
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-3863000
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1528000
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	17183000
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-9126000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-441712000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-261766000
	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	3615000
	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	0
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	0
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	320170000
	roiv	Milestone Payments MilestonePayments	140136000
	roiv	Milestone Payments MilestonePayments	0
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10560000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5100000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-154311000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	315070000
	roiv	Proceeds From Business Combination And Pipe Financing ProceedsFromBusinessCombinationAndPIPEFinancing	0
	roiv	Proceeds From Business Combination And Pipe Financing ProceedsFromBusinessCombinationAndPIPEFinancing	213424000
	roiv	Proceeds From Payment Of Subscription Receivable ProceedsFromPaymentOfSubscriptionReceivable	0
	roiv	Proceeds From Payment Of Subscription Receivable ProceedsFromPaymentOfSubscriptionReceivable	100000000
	roiv	Proceeds From Subsidiary Debt Financings Net ProceedsFromSubsidiaryDebtFinancingsNet	159899000
	roiv	Proceeds From Subsidiary Debt Financings Net ProceedsFromSubsidiaryDebtFinancingsNet	36400000
	roiv	Repayment Of Long Term Debt And Convertible Debt By Subsidiary RepaymentOfLongTermDebtAndConvertibleDebtBySubsidiary	14685000
	roiv	Repayment Of Long Term Debt And Convertible Debt By Subsidiary RepaymentOfLongTermDebtAndConvertibleDebtBySubsidiary	21590000
	roiv	Payment For Offering And Loan Costs PaymentForOfferingAndLoanCosts	2250000
	roiv	Payment For Offering And Loan Costs PaymentForOfferingAndLoanCosts	11843000
	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	0
	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	2247000
	roiv	Payments Of Taxes For The Repurchase Of Equity PaymentsOfTaxesForTheRepurchaseOfEquity	8329000
	roiv	Payments Of Taxes For The Repurchase Of Equity PaymentsOfTaxesForTheRepurchaseOfEquity	0
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	134635000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	314144000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-461388000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	367448000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2074034000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2141676000
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1612646000
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2509124000
	roiv	Offering Costs Included In Accounts Payable And Accrued Expenses OfferingCostsIncludedInAccountsPayableAndAccruedExpenses	0
	roiv	Offering Costs Included In Accounts Payable And Accrued Expenses OfferingCostsIncludedInAccountsPayableAndAccruedExpenses	8453000
	roiv	Common Shares And Other Consideration Issued For Purchase Of Property And Equipment CommonSharesAndOtherConsiderationIssuedForPurchaseOfPropertyAndEquipment	9694000
	roiv	Common Shares And Other Consideration Issued For Purchase Of Property And Equipment CommonSharesAndOtherConsiderationIssuedForPurchaseOfPropertyAndEquipment	0
	roiv	Noncash Other NoncashOther	691000
	roiv	Noncash Other NoncashOther	4579000
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1600000000
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3400000000
	us-gaap	Profit Loss ProfitLoss	-669700000
	us-gaap	Profit Loss ProfitLoss	-326700000
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1599021000
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2060400000
CY2022Q3	us-gaap	Restricted Cash RestrictedCash	13625000
CY2022Q1	us-gaap	Restricted Cash RestrictedCash	13634000
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1612646000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2074034000
	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P16Y1M6D
CY2022Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	143206000
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2908000
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	140298000
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	4300000
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	8700000
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	8700000
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	8700000
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	8700000
CY2022Q3	roiv	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	101200000
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	70300000
CY2022Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	53370000
CY2022Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	25036000
CY2022Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	3878000
CY2022Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	2331000
CY2022Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	2854000
CY2022Q3	roiv	Other Of Other Assets Current OtherOfOtherAssetsCurrent	14180000
CY2022Q1	roiv	Other Of Other Assets Current OtherOfOtherAssetsCurrent	22118000
CY2022Q3	us-gaap	Other Assets Current OtherAssetsCurrent	111847000
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	82220000
CY2022Q3	roiv	Accrued Research And Development Expenses Current AccruedResearchAndDevelopmentExpensesCurrent	66920000
CY2022Q1	roiv	Accrued Research And Development Expenses Current AccruedResearchAndDevelopmentExpensesCurrent	66188000
CY2022Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	27839000
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	44262000
CY2022Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	34056000
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	17081000
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	128815000
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	127531000
CY2022Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.007
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.009
CY2021Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.002
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.002
CY2022Q3	us-gaap	Interest Income Other InterestIncomeOther	5670000
CY2021Q3	us-gaap	Interest Income Other InterestIncomeOther	62000
	us-gaap	Interest Income Other InterestIncomeOther	7651000
	us-gaap	Interest Income Other InterestIncomeOther	133000
CY2022Q3	us-gaap	Interest Expense Other InterestExpenseOther	8335000
CY2021Q3	us-gaap	Interest Expense Other InterestExpenseOther	1552000
	us-gaap	Interest Expense Other InterestExpenseOther	10947000
	us-gaap	Interest Expense Other InterestExpenseOther	4065000
CY2022Q3	roiv	Other Income Expense OtherIncomeExpense	-5950000
CY2021Q3	roiv	Other Income Expense OtherIncomeExpense	-2202000
	roiv	Other Income Expense OtherIncomeExpense	-7035000
	roiv	Other Income Expense OtherIncomeExpense	374000
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-8615000
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3692000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-10331000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3558000

Files In Submission

Name	View Source	Status
0001140361-22-041175-index-headers.html	Edgar Link	pending
0001140361-22-041175-index.html	Edgar Link	pending
0001140361-22-041175.txt	Edgar Link	pending
0001140361-22-041175-xbrl.zip	Edgar Link	pending
brhc10044005_10q.htm	Edgar Link	pending
brhc10044005_31-1.htm	Edgar Link	pending
brhc10044005_31-2.htm	Edgar Link	pending
brhc10044005_32-1.htm	Edgar Link	pending
brhc10044005_32-2.htm	Edgar Link	pending
brhc10044005_ex10-1.htm	Edgar Link	pending
brhc10044005_ex10-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
brhc10044005_10q_htm.xml	Edgar Link	completed
image6.jpg	Edgar Link	pending
image7.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
roiv-20220930.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
roiv-20220930_def.xml	Edgar Link	unprocessable
roiv-20220930_lab.xml	Edgar Link	unprocessable
roiv-20220930_cal.xml	Edgar Link	unprocessable
roiv-20220930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ROIV
Roivant Sciences Ltd. Stock $roiv

2022 Q4 Form 10-Q Financial Statement

#000114036122041175 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ROIV Roivant Sciences Ltd. Stock $roiv

2022 Q4 Form 10-Q Financial Statement

#000114036122041175 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ROIV
Roivant Sciences Ltd. Stock $roiv